CEO: | Manuel Llobet |
Chief Finance Officer: | Shaun Furlong |
Independent Non-Executive Director: | Tunde Otulana |
Non-Executive Chairman: | Peter Jensen |
Non-Executive Dir: | Anthony Parker , Zheqing Shen , Cheryl MacDiarmid |
Address: | Dominion Way, Worthing, West Sussex, United Kingdom, BN14 8SA |
Phone: | +44 (0) 1903 844 700 |
Fax: | +44 (0) 1903 844 726 |
Website: | http://www.allergytherapeutics.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00B02LCQ05 |
Currency | UK Pounds |
Share Price | 3.13p |
Change Today | -0.18p |
% Change | -5.30 % |
52 Week High | 6.25 |
52 Week Low | 0.88 |
Volume | 576,496 |
Shares Issued | 4,766.44m |
Market Cap | £148.95m |
RiskGrade | 268 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:58 | 54,239 @ 3.05p |
15:26 | 12,500 @ 3.05p |
14:03 | 343 @ 3.24p |
14:00 | 2,500 @ 3.38p |
14:00 | 2,500 @ 3.38p |
You are here: research